Logo image of HLMN

HILLMAN SOLUTIONS CORP (HLMN) Stock Fundamental Analysis

NASDAQ:HLMN - Nasdaq - US4316361090 - Common Stock - Currency: USD

10.02  -0.1 (-0.99%)

After market: 10.02 0 (0%)

Fundamental Rating

3

HLMN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. HLMN has a medium profitability rating, but doesn't score so well on its financial health evaluation. HLMN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

HLMN had positive earnings in the past year.
In the past year HLMN had a positive cash flow from operations.
In the past 5 years HLMN reported 4 times negative net income.
Of the past 5 years HLMN 4 years had a positive operating cash flow.
HLMN Yearly Net Income VS EBIT VS OCF VS FCFHLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

HLMN has a worse Return On Assets (0.74%) than 64.00% of its industry peers.
HLMN has a Return On Equity of 1.46%. This is in the lower half of the industry: HLMN underperforms 63.20% of its industry peers.
With a Return On Invested Capital value of 2.78%, HLMN is not doing good in the industry: 69.60% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for HLMN is significantly below the industry average of 11.00%.
The 3 year average ROIC (1.94%) for HLMN is below the current ROIC(2.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.74%
ROE 1.46%
ROIC 2.78%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
HLMN Yearly ROA, ROE, ROICHLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

HLMN has a Profit Margin of 1.17%. This is in the lower half of the industry: HLMN underperforms 63.20% of its industry peers.
HLMN has a Operating Margin (6.03%) which is in line with its industry peers.
HLMN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 48.07%, HLMN belongs to the top of the industry, outperforming 90.40% of the companies in the same industry.
HLMN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.03%
PM (TTM) 1.17%
GM 48.07%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
HLMN Yearly Profit, Operating, Gross MarginsHLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLMN is destroying value.
HLMN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HLMN has been increased compared to 5 years ago.
HLMN has a better debt/assets ratio than last year.
HLMN Yearly Shares OutstandingHLMN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
HLMN Yearly Total Debt VS Total AssetsHLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 1.83 indicates that HLMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
HLMN's Altman-Z score of 1.83 is on the low side compared to the rest of the industry. HLMN is outperformed by 62.40% of its industry peers.
The Debt to FCF ratio of HLMN is 7.18, which is on the high side as it means it would take HLMN, 7.18 years of fcf income to pay off all of its debts.
HLMN has a Debt to FCF ratio (7.18) which is in line with its industry peers.
A Debt/Equity ratio of 0.59 indicates that HLMN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, HLMN is not doing good in the industry: 63.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 7.18
Altman-Z 1.83
ROIC/WACC0.29
WACC9.71%
HLMN Yearly LT Debt VS Equity VS FCFHLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

HLMN has a Current Ratio of 2.26. This indicates that HLMN is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.26, HLMN perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
HLMN has a Quick Ratio of 2.26. This is a bad value and indicates that HLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLMN has a worse Quick ratio (0.67) than 88.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 0.67
HLMN Yearly Current Assets VS Current LiabilitesHLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

HLMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
HLMN shows a decrease in Revenue. In the last year, the revenue decreased by -0.26%.
Measured over the past years, HLMN shows a small growth in Revenue. The Revenue has been growing by 3.93% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-0.26%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%0.5%

3.2 Future

The Earnings Per Share is expected to grow by 19.22% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.74% on average over the next years.
EPS Next Y10.63%
EPS Next 2Y12.97%
EPS Next 3Y17.21%
EPS Next 5Y19.22%
Revenue Next Year4.32%
Revenue Next 2Y4.9%
Revenue Next 3Y6.43%
Revenue Next 5Y7.74%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HLMN Yearly Revenue VS EstimatesHLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
HLMN Yearly EPS VS EstimatesHLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.27, which indicates a rather expensive current valuation of HLMN.
69.60% of the companies in the same industry are more expensive than HLMN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.63, HLMN is valued a bit cheaper.
HLMN is valuated rather expensively with a Price/Forward Earnings ratio of 17.42.
HLMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HLMN is cheaper than 68.80% of the companies in the same industry.
HLMN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.27
Fwd PE 17.42
HLMN Price Earnings VS Forward Price EarningsHLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLMN indicates a somewhat cheap valuation: HLMN is cheaper than 68.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLMN indicates a somewhat cheap valuation: HLMN is cheaper than 73.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.08
EV/EBITDA 12.11
HLMN Per share dataHLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as HLMN's earnings are expected to grow with 17.21% in the coming years.
PEG (NY)1.81
PEG (5Y)N/A
EPS Next 2Y12.97%
EPS Next 3Y17.21%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HLMN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HILLMAN SOLUTIONS CORP

NASDAQ:HLMN (2/21/2025, 8:25:44 PM)

After market: 10.02 0 (0%)

10.02

-0.1 (-0.99%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-18 2025-02-18/bmo
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners101.7%
Inst Owner Change0.4%
Ins Owners1.05%
Ins Owner Change0.52%
Market Cap1.97B
Analysts82.67
Price Target13.8 (37.72%)
Short Float %1.14%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.8%
Min EPS beat(2)-7.7%
Max EPS beat(2)-1.89%
EPS beat(4)2
Avg EPS beat(4)4.19%
Min EPS beat(4)-7.7%
Max EPS beat(4)14.75%
EPS beat(8)5
Avg EPS beat(8)39%
EPS beat(12)9
Avg EPS beat(12)111.01%
EPS beat(16)11
Avg EPS beat(16)213.82%
Revenue beat(2)0
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-2.16%
Max Revenue beat(2)-0.57%
Revenue beat(4)0
Avg Revenue beat(4)-2.38%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)-0.57%
Revenue beat(8)0
Avg Revenue beat(8)-2.88%
Revenue beat(12)0
Avg Revenue beat(12)-2.79%
Revenue beat(16)3
Avg Revenue beat(16)-1.52%
PT rev (1m)-0.92%
PT rev (3m)9.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.21%
EPS NY rev (3m)0.43%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)-0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 19.27
Fwd PE 17.42
P/S 1.34
P/FCF 20.08
P/OCF 10.74
P/B 1.67
P/tB N/A
EV/EBITDA 12.11
EPS(TTM)0.52
EY5.19%
EPS(NY)0.58
Fwd EY5.74%
FCF(TTM)0.5
FCFY4.98%
OCF(TTM)0.93
OCFY9.31%
SpS7.49
BVpS6.01
TBVpS-1.28
PEG (NY)1.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 1.46%
ROCE 4.28%
ROIC 2.78%
ROICexc 2.84%
ROICexgc 9.65%
OM 6.03%
PM (TTM) 1.17%
GM 48.07%
FCFM 6.66%
ROA(3y)-0.11%
ROA(5y)-0.56%
ROE(3y)-0.26%
ROE(5y)-2.17%
ROIC(3y)1.94%
ROIC(5y)1.62%
ROICexc(3y)1.97%
ROICexc(5y)1.64%
ROICexgc(3y)6.76%
ROICexgc(5y)6%
ROCE(3y)2.98%
ROCE(5y)2.49%
ROICexcg growth 3Y110.94%
ROICexcg growth 5Y37.21%
ROICexc growth 3Y112.78%
ROICexc growth 5Y43.98%
OM growth 3Y102.86%
OM growth 5Y36.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.57%
GM growth 5Y2.32%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 7.18
Debt/EBITDA 3.16
Cap/Depr 65.53%
Cap/Sales 5.79%
Interest Coverage 250
Cash Conversion 83.78%
Profit Quality 568.63%
Current Ratio 2.26
Quick Ratio 0.67
Altman-Z 1.83
F-Score6
WACC9.71%
ROIC/WACC0.29
Cap/Depr(3y)59.2%
Cap/Depr(5y)51.21%
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y10.63%
EPS Next 2Y12.97%
EPS Next 3Y17.21%
EPS Next 5Y19.22%
Revenue 1Y (TTM)-0.26%
Revenue growth 3Y1.08%
Revenue growth 5Y3.93%
Sales Q2Q%0.5%
Revenue Next Year4.32%
Revenue Next 2Y4.9%
Revenue Next 3Y6.43%
Revenue Next 5Y7.74%
EBIT growth 1Y45.81%
EBIT growth 3Y105.05%
EBIT growth 5Y41.6%
EBIT Next Year153.59%
EBIT Next 3Y45.7%
EBIT Next 5Y31.1%
FCF growth 1Y-43.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.98%
OCF growth 3YN/A
OCF growth 5Y28.46%